Prior authorization recommended for fusion procedures

Prior authorization is recommended for fusion procedures. Documentation should justify fusion over non‑surgical alternatives given variable evidence and higher complication/re-operation rates; when fusion is requested, provide indication‑specific evidence (e.g., radiographic grade of spondylolisthesis, dynamic instability measurements, sagittal imbalance metrics) and reference applicable guideline rationale.

• Provide indication-specific justification when requesting authorization for fusion (e.g., spondylolisthesis grade, dynamic translation ≥4 mm or ≥10° angular motion, sagittal vertical axis >5 cm or pelvic tilt >20°, PI-LL ≥10°).
• If fusion is being considered for degenerative disc disease, document why intensive conservative therapy and alternatives (e.g., intensive interdisciplinary rehab/CBT) were inadequate.

Prior authorization justification

Prior authorization requests must include clinical justification that correlates imaging findings with exam and prior non‑operative management. For elective fusion, show failure of appropriate conservative therapy (duration depends on indication) unless urgent waivers apply.

• Document trial of conservative therapy: typically ≥6 weeks (radiculopathy/spondylolisthesis) or up to 3 months/6–12 months for some lumbar fusion indications; physical therapy must be in-person and within past year.
• Include prior treatments: patient education, in-person PT notes, medications (NSAIDs/acetaminophen/TCAs), and injections where appropriate.
• State reason for any waiver of conservative therapy (eg, spinal cord compression, cauda equina, progressive neurologic deficit, severe weakness).

Prior authorization not specified in excerpt

Some excerpts of this document do not specify administrative prior‑authorization rules for all procedures; providers must follow payer/plan‑specific PA processes.

• Where the CPB is silent about PA for a specific code or procedure, obtain and follow the plan’s prior authorization policy before scheduling.
• Clinical policy content supplements but does not replace plan benefit terms — confirm member coverage and PA requirements with the plan.

Clinical indication documentation

Document clinical indications thoroughly: include focused history, neurologic and physical exam (performed or reviewed by the operating surgeon), symptom severity/progression, and correlation to imaging.

• Include neurologic exam findings, MRC muscle strength grades where relevant (eg, 4− or less triggers urgent consideration).
• Record symptom duration, severity scores (eg, VAS, ODI, NDI, JOA), and any progressive neurologic deficits.
• Describe level(s) and side(s) of nerve‑root compression with imaging reports and correlate to clinical findings.

Prior authorization: not specified in this excerpt

The CPB text contains windows where no explicit administrative prior‑authorization requirements are stated. In those cases, clinical criteria are provided but administrative PA rules may not be present in the excerpt.

• Do not assume absence of PA — verify plan/provider portal for required prior authorization steps.
• Use the CPB clinical criteria to support medical necessity when submitting documentation.

Pre-op smoking-cessation relevance

Pre-operative smoking status and cessation efforts are relevant to authorization and surgical optimization. Nicotine use increases risk of pseudarthrosis and complications and may influence approval or require documentation of cessation.

• Document smoking status in the medical record and include counseling/cessation interventions.
• For cervical or lumbar pseudoarthrosis not requiring urgent intervention, members should be nicotine-free ≥6 weeks prior to fusion.
• Active tobacco use is associated with higher 90‑day readmission and increased non‑union risk.

Pre-operative smoking cessation recommended

Pre-operative smoking cessation is recommended. Provide objective evidence of cessation when required: lab confirmation and documentation of counseling/therapy per plan.

• When cessation is required, submit blood or urine nicotine level ≤10 ng/ml drawn within 6 weeks prior to surgery (lab report, not surgeon summary).
• ERAS and guideline-based programs recommend combined cessation therapy (behavioral + pharmacotherapy/NRT) for at least 4 weeks before lumbar fusion when used as part of pre-op optimization.

Follow plan-specific prior authorization

Always follow plan‑specific prior authorization procedures. Clinical policy guidance does not replace the payer’s administrative PA process — obtain PA through the plan channel and submit required supporting documentation.

• Confirm member eligibility and PA requirements via the payer’s provider portal or phone line prior to surgery.
• Attach CPB‑relevant clinical criteria and supporting imaging, PT notes, and nicotine testing results when applicable.

This window contains only literature references

Some policy windows contain only literature review or background content and do not state operational PA rules. Treat these as informational and not as standalone authorization guidance.

• Use background/literature sections to support clinical rationale but not in lieu of plan PA forms or checklists.
• If the excerpted window lacks PA statements, include full CPB citations when submitting medical necessity rationale.

Clinical Policy Bulletins are not offers of coverage

Clinical Policy Bulletins are informational tools to assist in administering plan benefits; they are not offers of coverage or a substitute for plan benefits. Treat plan documents as authoritative for coverage determinations.

• Include note in submissions that CPBs are supplemental guidance and that final coverage is determined by the member’s plan and contract.
• Providers retain responsibility for medical advice and should document decision‑making accordingly.

No denial triggers or authorization requirements present in these excerpts

No specific denial triggers or administrative authorization requirements are present in some excerpts. However, failure to document required conservative therapy, imaging, nicotine cessation, or indications for waiver may lead to denial.

• Common denial reasons include lack of documentation of adequate conservative therapy, missing imaging reports or surgeon addenda, absence of objective neurologic findings correlating to imaging, or failure to provide nicotine cessation lab reports when required.
• If urgent indications exist (cord compression, cauda equina, progressive neuro deficit), document them clearly to support waiver of conservative therapy.

Nicotine cessation evidence

When nicotine cessation is required, provide objective laboratory evidence. Lab reports (blood or urine) demonstrating nicotine ≤10 ng/ml within 6 weeks before surgery are required; surgeon summaries alone are insufficient.

• Submit 80323 (alkaloids) lab result or equivalent showing blood/urine nicotine ≤10 ng/ml drawn within 6 weeks of planned surgery.
• If disagreement exists between surgeon and official radiology report, include a written addendum documenting discussion and agreement/disagreement with the interpreting radiologist.

Imaging report and addendum requirement

Submit the official written imaging report for CT/MRI/myelogram. If the operating surgeon disagrees with the official interpretation, include documented discussion with the interpreting radiologist and a written addendum.

• Imaging should be performed within the past year or after onset of current symptoms or relevant surgery, whichever is sooner.
• If addendum is provided, ensure it is linked to the official report and accompanies the PA submission.

Required clinical documentation

Required clinical documentation for PA includes focused history, neurologic and physical exam by or reviewed by the operating surgeon, imaging reports, and evidence of prior conservative management where required.

• Provide operative-level correlation: imaging-confirmed nerve‑root compression(s) with matching clinical signs/symptoms and earlier non-operative management details.
• Include PT notes, medication trials, injection records, and duration of conservative care.

Preoperative documentation for FBSS and revision surgery

For failed back surgery syndrome (FBSS) and revision procedures, preoperative documentation should include detailed history, identification of spinal etiology, psychosocial assessment, and records of prior surgeries and therapies.

• Provide prior operative reports, imaging demonstrating recurrent or residual pathology, pain and functional scores, and psychosocial evaluation.
• Document rationale for revision or fusion related to prior surgery (eg, pseudarthrosis, hardware failure, recurrent stenosis).

Clinical indication and guideline linkage

Link clinical indications to current guideline recommendations and evidence when justifying procedures. Cite guideline-based thresholds and trial results to support medical necessity.

• When applicable, reference ACP/APS, NASS, or other guideline recommendations (eg, imaging for persistent radiculopathy, consideration of intensive rehab prior to fusion).
• Use guideline language to explain choice of fusion vs decompression or rehabilitation alternatives.

Suggested clinical documentation

Include suggested clinical documentation and outcome measures to support medical necessity and to describe baseline severity and expected benefit.

• Suggested measures: VAS, ODI, JOA, NDI, SF‑36; include number of operative levels and relevant radiographic measurements (eg, slip grade, canal occupying ratio, sagittal parameters).
• Report prior non-operative program content and duration (eg, intensive rehab hours, CBT participation).

Clinical outcome measures referenced

Clinical outcome measures commonly referenced in the evidence base should be provided to quantify severity and response to prior treatments when submitting PA or appeals.

• Commonly used instruments: VAS (pain), ODI (disability), NDI, JOA, SF‑36.
• Provide baseline scores and recent changes after conservative therapy to justify progression to surgery.

Document smoking status and cessation efforts

Document smoking status and all cessation efforts in the chart. Include counseling, pharmacotherapy, NRT, and timing relative to the planned surgery.

• Record date and content of smoking‑cessation counseling, medications prescribed, and participation in cessation programs.
• If lab testing is used, include specimen date to show compliance with timing requirements (eg, within 6 weeks).

Carboxyhemoglobin (SpCO) screening literature notes

Carboxyhemoglobin (SpCO) screening literature provides context on non‑invasive CO measurements in smokers but thresholds vary. Use SpCO cautiously and follow plan/lab guidance for objective nicotine testing requirements.

• SpCO thresholds in literature can be up to ~9% for smokers; however, SpCO alone may not substitute for nicotine metabolite testing (blood/urine nicotine levels) required by some plans.
• If using SpCO screening, document timing relative to last cigarette and understand its limitations in clinical submissions.

Policy history and provider responsibility

Policy history and provider responsibility statements clarify that CPBs are periodically reviewed and that treating providers are responsible for patient care decisions and documentation.

• Reference the policy Effective Date (12/14/2007) and most recent review (see policy history) when assembling documentation.
• Treating providers remain responsible for medical advice; include attending surgeon’s exam and rationale in submissions.

Non-surgical therapies to attempt before fusion

Non-surgical therapies should be attempted before elective fusion for many degenerative indications. Intensive interdisciplinary rehab, structured exercise, and CBT are evidence-supported alternatives and should be documented when used.

• Document components and duration of non-surgical programs (eg, hours of intensive rehab, CBT participation, home vs in‑person PT).
• For non-radicular LBP, consider intensive interdisciplinary rehab as an alternative to fusion and provide rationale if fusion pursued despite such programs.

Conservative therapy prior to elective fusion

Elective fusion generally requires documented failure of conservative therapy; the required trial length depends on the indication (commonly ≥6 weeks for some conditions, and up to 3–12 months for others).

• Physical therapy should be in-person and the member should participate for the entire required duration; confirm with PT notes or claims history.
• If a waiver is claimed (urgent indications), clearly document the qualifying urgent condition.

Clinical sequencing guidance

Clinical sequencing guidance from the literature may inform procedure selection (eg, favoring anterior approaches over laminoplasty when pre-operative canal occupying ratio ≥60%); document imaging metrics that support surgical approach.

• When choosing laminoplasty vs corpectomy or fusion, include canal occupying ratio, sagittal alignment, and instability data to justify approach.
• Cite relevant study findings when used to support clinical decision-making in PA submissions.

Conservative therapy first

Conservative therapy is the first-line approach for mild conditions; reserve surgery for severe or progressive symptoms, and document attempts at non-operative care and rationale for escalation.

• For mild symptoms, provide evidence that conservative care was tried and insufficient prior to considering surgery.
• If symptoms are severe/progressive, document neurologic deficits, imaging, and timing to support urgency or waiver of conservative therapy.

No step therapy requirements described in background

No step‑therapy administrative requirements are described in the background sections of this CPB. However, absence in the CPB does not preclude plan‑level step therapy policies; verify with the payer.

• Confirm whether the member’s plan imposes step therapy or other utilization management rules that affect authorization.
• If step therapy exists at plan level, document prior required steps and outcomes in PA submission.

Comparative cost-effectiveness modeling for smoking cessation

Comparative cost‑effectiveness modeling supports pre-operative smoking-cessation interventions for lumbar fusion (combined interventions can be cost‑saving). Consider documenting smoking‑cessation program enrollment as part of pre-op optimization.

• When applicable, note participation in behavioral counseling, NRT, bupropion/varenicline, or combined interventions as part of pre-op care.
• Include evidence of program enrollment or completion in the PA or optimization documentation.